| | Hang Seng Index | 26.020
HKD | -0.340 | -1.290% | 624.98M | 16.36B | 23.260 (+11.867%)
HKD as at 2025/02/25 | | |
| | Hang Seng China Enterprises | 93.500
HKD | -1.120 | -1.184% | 114.75M | 10.81B | 86.975 (+7.502%)
HKD as at 2025/02/25 | | |
| | Hang Seng TECH Index | 5.675
HKD | -0.035 | -0.613% | 1.75B | 9.96B | 5.580 (+1.699%)
HKD as at 2025/02/25 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 5.960
HKD | -0.090 | -1.488% | 164.37M | 992.10M | 6.590 (-9.560%)
HKD as at 2025/02/25 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.416
HKD | +0.024 | +1.724% | 402.84M | 563.91M | 1.831 (-22.682%)
HKD as at 2025/02/25 | | |
| | Hang Seng TECH Index | 12.180
HKD | -0.090 | -0.733% | 42.43M | 520.40M | 12.133 (+0.390%)
HKD as at 2025/02/24 | | |
| | Hang Seng TECH Index | 5.760
HKD | -0.040 | -0.690% | 56.86M | 329.92M | 5.659 (+1.794%)
HKD as at 2025/02/25 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 1.928
HKD | +0.048 | +2.553% | 147.62M | 281.26M | 2.726 (-29.271%)
HKD as at 2025/02/25 | | |
| | CSI 300 | 50.260
HKD | -0.160 | -0.317% | 5.16M | 260.12M | 43.473 (+15.611%)
HKD as at 2025/02/25 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 5.915
HKD | -0.150 | -2.473% | 35.56M | 213.37M | 5.000 (+18.307%)
HKD as at 2025/02/25 | | |
| | FTSE China A50 | 15.950
HKD | -0.120 | -0.747% | 10.57M | 169.18M | 13.749 (+16.008%)
HKD as at 2025/02/24 | | |
| | Hang Seng China Enterprises | 10.830
HKD | -0.010 | -0.092% | 12.04M | 130.54M | 10.808 (+0.201%)
HKD as at 2025/02/24 | | |
| | Hang Seng Hong Kong-Listed Biotech Index | 17.280
HKD | -0.300 | -1.706% | 7.37M | 127.76M | 10.297 (+67.813%)
HKD as at 2025/02/25 | | |
| | London Gold Fixing Price | 2,425.000
HKD | +6.000 | +0.248% | 31.98K | 77.59M | N/A | | |
| | FTSE China A50 | 14.850
HKD | -0.120 | -0.802% | 5.10M | 76.00M | 12.681 (+17.102%)
HKD as at 2025/02/25 | | |
| | MSCI China A 50 Connect Index (net total return index) | 26.900
HKD | -0.180 | -0.665% | 1.19M | 32.23M | 22.947 (+17.226%)
HKD as at 2025/02/25 | | |
| | MSCI Asia APEX 50 | 65.380
HKD | -0.800 | -1.209% | 415.76K | 27.30M | 57.370 (+13.962%)
HKD as at 2025/02/24 | | |
| | CME CF Ether-Dollar Reference Rate - Asia Pacific Variant | 10.580
HKD | -0.410 | -3.731% | 2.47M | 25.97M | 5.740 (+84.330%)
HKD as at 2025/02/25 | | |
| | CSI 300 | 32.880
HKD | -0.260 | -0.785% | 768.40K | 25.42M | 28.366 (+15.915%)
HKD as at 2025/02/24 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | ChiNext Index (HKD)(CNH) | 6.015
HKD | -0.150 | -2.433% | 3.28M | 20.03M | 4.284 (+40.400%)
HKD as at 2025/02/24 | | |
| | SSE Science and Technology Innovation Board 50 Index | 11.740
HKD | -0.180 | -1.510% | 1.47M | 17.32M | 10.021 (+17.157%)
HKD as at 2025/02/25 | | |
| | CSI 300 | 46.120
CNY | -0.160 | -0.346% | 348.75K | 16.10M | 40.598 (+13.601%)
CNY as at 2025/02/25 | | |
| | Hang Seng High Dividend Yield | 30.480
HKD | -0.060 | -0.196% | 514.01K | 15.70M | 24.714 (+23.330%)
HKD as at 2025/02/24 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 3.792
HKD | +0.020 | +0.530% | 4.01M | 15.21M | 4.925 (-23.010%)
HKD as at 2025/02/24 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | CSI 300 | 4.608
HKD | -0.060 | -1.285% | 3.06M | 14.21M | 3.748 (+22.932%)
HKD as at 2025/02/25 | | |
| | FTSE US Treasury 20+ Years Index | 67.380
HKD | -0.400 | -0.590% | 195.50K | 13.19M | 70.043 (-3.802%)
HKD as at 2025/02/24 | | |
| | SSE Science and Technology Innovation Board 50 Index | 8.495
HKD | -0.185 | -2.131% | 1.54M | 13.09M | 7.279 (+16.702%)
HKD as at 2025/02/24 | | |
| | CME CF Bitcoin Reference Rate- Asia Pacific Variant | 13.560
HKD | -0.140 | -1.022% | 930.40K | 12.56M | 11.063 (+22.573%)
HKD as at 2025/02/25 | | |
| | CME Ether Futures | 20.740
HKD | -0.800 | -3.714% | 478.51K | 9.94M | 13.011 (+59.405%)
HKD as at 2025/02/24 | | |
| | MSCI China | 27.160
HKD | -0.280 | -1.020% | 345.34K | 9.43M | 23.954 (+13.383%)
HKD as at 2025/02/24 | | |